Krystal Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Revenue	333.45	290.52	50.7	-	-	-	Upgrade
Revenue Growth (YoY)	247.53%	473.02%	-	-	-	-	Upgrade
Cost of Revenue	22.67	20.06	3.09	-	-	-	Upgrade
Gross Profit	310.78	270.45	47.61	-	-	-	Upgrade
Selling, General & Admin	120.35	113.69	98.4	78.84	41.99	15.06	Upgrade
Research & Development	56.87	53.57	46.43	42.46	27.88	17.94	Upgrade
Operating Expenses	177.22	167.26	144.83	121.3	69.88	33	Upgrade
Operating Income	133.56	103.2	-97.23	-121.3	-69.88	-33	Upgrade
Interest Expense	-	-	-	-	-1.49	-	Upgrade
Interest & Investment Income	29.47	29.66	22.62	5.22	0.2	0.83	Upgrade
EBT Excluding Unusual Items	163.02	132.86	-74.6	-116.08	-71.17	-32.17	Upgrade
Gain (Loss) on Sale of Assets	-	-	100	-	-	-	Upgrade
Legal Settlements	-25	-37.5	-12.5	-25	-	-	Upgrade
Pretax Income	138.02	95.36	12.9	-139.98	-69.57	-32.17	Upgrade
Income Tax Expense	14.06	6.2	1.97	-	-	-	Upgrade
Net Income	123.96	89.16	10.93	-139.98	-69.57	-32.17	Upgrade
Net Income to Common	123.96	89.16	10.93	-139.98	-69.57	-32.17	Upgrade
Net Income Growth	116.86%	715.58%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	29	29	27	25	22	19	Upgrade
Shares Outstanding (Diluted)	30	30	28	25	22	19	Upgrade
Shares Change (YoY)	4.32%	7.16%	8.87%	14.85%	18.15%	18.15%	Upgrade
EPS (Basic)	4.32	3.12	0.40	-5.49	-3.13	-1.71	Upgrade
EPS (Diluted)	4.16	3.00	0.39	-5.49	-3.13	-1.71	Upgrade
EPS Growth	109.01%	669.23%	-	-	-	-	Upgrade
Free Cash Flow	129.32	119.18	-100.6	-153.55	-116.27	-40.93	Upgrade
Free Cash Flow Per Share	4.33	4.01	-3.63	-6.02	-5.24	-2.18	Upgrade
Gross Margin	93.20%	93.09%	93.90%	-	-	-	Upgrade
Operating Margin	40.05%	35.52%	-191.77%	-	-	-	Upgrade
Profit Margin	37.18%	30.69%	21.56%	-	-	-	Upgrade
Free Cash Flow Margin	38.78%	41.02%	-198.43%	-	-	-	Upgrade
EBITDA	135.91	105.66	-93.32	-118.65	-67.11	-31.15	Upgrade
EBITDA Margin	40.76%	36.37%	-184.07%	-	-	-	Upgrade
D&A For EBITDA	2.35	2.47	3.91	2.64	2.77	1.85	Upgrade
EBIT	133.56	103.2	-97.23	-121.3	-69.88	-33	Upgrade
EBIT Margin	40.05%	35.52%	-191.77%	-	-	-	Upgrade
Effective Tax Rate	10.19%	6.50%	15.24%	-	-	-	Upgrade

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q